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Objectives: Surgical remodeling of the left ventricle has involved various techniques
of volume reduction. This study evaluates factors that influence long-term survival
results with 3 operative methods.
Methods: From 1979 to 2000, 157 patients (134 men, mean age 61 years) underwent
operations for class III or IV congestive heart failure, angina, ventricular tachyar-
rhythmia, and sudden death after anteroseptal myocardial infarction. The preoper-
ative ejection fraction was 28%  0.9% (mean  standard error), and the pulmo-
nary artery occlusive pressure was 15  0.07 mm Hg. Cardiogenic shock was
present in 26 patients (16%), and an intra-aortic balloon pump was used in 48
patients (30%). The type of procedure depended on the extent of endocardial disease
and was aimed at maintaining the ellipsoid shape of the left ventricle cavity. In
group I patients (n  65), radical aneurysm resection and linear closure were
performed. In group II patients (n  70), septal dyskinesis was reinforced with a
patch (septoplasty). In group III patients (n  22), ventriculotomy closure was
performed with an intracavitary oval patch.
Results: Hospital mortality was 16% (25/157) and was similar among the groups.
Actuarial survival up to 18 years was better with a preoperative ejection fraction of
26% or greater (P  .004) and a pulmonary artery occlusive pressure of 17 mm Hg
or less (P  .05). Survival was worse in patients who had intra-aortic balloon pump
support (P .03). Five-year survival for all patients in group III was higher than for
patients in group II (67% vs 47%, P  .04).
Conclusions: Factors that improved long-term survival after left ventricular surgical
remodeling were intraventricular patch repair, preoperative ejection fraction of 26%
or greater, and pulmonary artery occlusive pressure of 17 mm Hg or less without the
need for balloon pump assist.
Surgical methods to restore the volume and shape of the left ventricle(LV), after an extensive myocardial infarction (MI) that has resultedin cavity remodeling (LV aneurysm), have evolved over the years.Present techniques attempt to reconstruct the natural ellipsoid shape ofthe LV cavity, which offers the most favorable geometry for LVperformance and patient survival.1-3 The long-term surgical results
have been reported as an observational experience by various centers, most recently
by the RESTORE group.4,5 This study evaluates the factors affecting the long-term
survival of patients who underwent 3 methods of LV cavity restoration.
Patients and Methods
Patient Selection
A retrospective review was performed of 157 consecutive patients who underwent LV
volume reduction surgery by 1 of 3 surgical techniques from 1979 to 2000. All procedures
were performed by the senior author (H.B.). Table 1 summarizes the characteristics of all
patients. The age range of the patients was from 30 to 85 years (mean 61 0.08 years SEM).
There were 134 male patients (85%). All patients had had an anteroseptal MI in the past, and
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TABLE 1. Preoperative patient characteristics
Variable
All patients
(n  157)
Group I
(n  65)
Group II
(n  70)
Group III
(n  22) P value
Age, y  SEM (range) 61 0.8 (30–85) 62 1.25 (39–85) 60 1.1 (30–78) 62.5 2.2 (40–84) .731
Male/female 134/23 57/8 58/12 19/3 .722
CHF, n (%) 117 (74) 40 (61) 59 (88) 15 (68) .032*†
Class III and IV 84 (53) 27 (41) 42 (60) 15 (68) .04*†
Angina, n (%) 103 (65) 43 (66) 44 (62) 16 (72) .691
VT, n (%) 82 (51) 16 (25) 56 (80) 10 (45) .001*
SD, n (%) 60 (38) 17 (26) 38 (54) 5 (22) .001*‡
CS, n (%) 26 (16) 8 (12) 17 (24) 1 (4.5) .03*‡
Recent MI, n (%) 66 (42) 27 (41) 25 (35) 14 (63) .068
CHF, Congestive heart failure; VT, ventricular tachyarrhythmia; SD, sudden death; CS, cardiogenic shock; MI, myocardial infarction (within 30 d of
admission).
*Comparing groups I and II.
†Comparing groups I and III.
‡Comparing groups II and III.
TABLE 2. Preoperative hemodynamic findings
Variable n
All patients
157
Group I
65
Group II
70
Group III
22 P value
EF %  SEM (n  131) (range) 28.8 0.9 (7–56) 32 1.2 (15–49) 27.8 1.3 (7–56) 22.7 2.7 (10–40) .002*†
CI (L · min1 · m2) n  121 (range) 2.5 0.05 (1.3–4.4) 2.5 0.07 (1.5–3.9) 2.5 0.08 (1.3–4.4) 1.99 0.15 (1.3–2.4) .04†‡
PAO (mm Hg) n  127 (range) 15.7 0.75 (3–40) 14.3 1.1 (3–38) 16.4 1.0 (4–40) 20.1 3.1 (7–33) .141
EDP (mm Hg) n  53 (range) 20 1 (7–38) 17.4 1.5 (11–30) 20.2 1.3 (7–30) 23 2.7 (11–38) .131
EF, Ejection fraction; CI, cardiac index; PAO, pulmonary artery occlusive (wedge) pressure; EDP, left ventricular end-diastolic pressure; SEM, standard error
of mean.
*Comparing groups I and II.
†Comparing groups I and III.
‡Comparing groups II and III.
TABLE 3. Operative procedures: Early and late mortality and follow-up
Variable All patients (n  157) Group I (n  65) Group II (n  70) Group III (n  22) P value
CABG 126 (80) 55 (85) 56 (80) 15 (68) .398
LITA graft 43 (34) 18 (32) 11 (19) 14 (93) .002*†
Endarterectomy 12 (10) 6 (11) 4 (17) 2 (13) .716
Grafts/patients (mean  SE) 2.96 .11 3.03 .17 2.87 .17 3.0 42 .493
Perioperative IABP 48(30) 14 (21) 26 (37) 8 (36) .133
Elective/emergency 13/35 3/11 10/16 0/8 .089
Mapping/cryo 81 (51) 16 (25) 56 (80) 9 (41) .001*
AICD 16 (10) 3 (5) 11 (15) 2 (9) .101
Emergency operation 74 (47) 26 (40) 46 (65) 2 (9) .003*†‡
CPB, min (mean  SE) (range) 173 6.2 (50–442) 159 10 (52–442) 186 8 (50–324) 168 18 (67–267) .113
ACC, min (mean  SE) (range) 101 3.8 (20–251) 96 6.3 (20–251) 106 5.2 (24–198) 102 12.5 (29–174) .503
Other procedures (valves) 5 (3%) 3 0 1/1(ASD) .127
Mortality (hospital/30 d) 25 (16) 10 (15) 12 (17) 3 (13) .460
Follow-up, mo mean  SE 61.9 5.3 67.9 9.6 63.8 7.6 37.9 6.6 .185
Mortality (follow-up), n 76 37 38 1
Lost to follow-up 20 (14.7) 9 (16.3) 9 (14.5) 2 (9)
Presently surviving (3/2002) 36 9 11 16
70 y old 14 5 4 5
CABG, Coronary artery bypass graft; LITA, left internal thoracic artery; IABP, intra-aortic balloon pump; Cryo, cryoablation; AICD, automatic implantable
cardioverter-defibrillator; CPB, cardiopulmonary bypass; ACC, aortic crossclamp; ASD, atrial septal defect.
*Comparing groups I and II.
†Comparing groups I and III.
‡Comparing groups II and III.
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66 patients (42%) had had an MI within the month before admis-
sion. All patients had a large anterior wall LV dyskinetic aneu-
rysm. The indications for operation were congestive heart failure,
cardiogenic shock (systolic blood pressure  80 mm Hg and
cardiac index  1.8 L · min1 · m2), angina pectoris, ventricular
tachyarrhythmia (VT), and sudden death. The preoperative data on
LV systolic function and pulmonary artery occlusive (PAO) pres-
sure are shown in Table 2. Patients with isolated lateral or posterior
wall aneurysm or with LV dysfunction and predominant mitral
valve insufficiency were not included in this survey.
Complete myocardial revascularization was performed in 126
patients (80%) by using saphenous vein segments and the left
internal thoracic artery (Table 3). The left anterior descending
artery was bypassed whenever possible. If the left anterior de-
scending artery or any other major coronary artery had an exten-
sively narrowed lumen, endarterectomy was performed to establish
proximal blood flow, especially to the septal perforators. In 3
patients, the right internal thoracic artery was used as a free graft
to bypass the left coronary artery branches. Sequential coronary
grafts were performed whenever possible.6
The operations were performed on an emergency or urgent
basis (within 12 to 24 hours of admission) in 74 (47%) of the
patients. Additional procedures included mitral valve repair or
replacement in 3 patients, aortic valve replacement in 1 patient,
and atrial septal defect closure in 1 patient. An automatic implant-
able cardioverter-defibrillator was implanted in 16 patients. In our
early experience, intrapericardial automatic implantable cardio-
verter-defibrillator patches were placed in 44 patients during sur-
gery.
Surgical Techniques
The details of techniques used in our center have been pub-
lished.7,8 In brief, normothermic cardiopulmonary bypass was
established, and the heart was maintained beating, empty, and in
sinus rhythm. The blood pressure was kept at 70 to 80 mm Hg.
Left ventriculotomy was made parallel and lateral to the course of
the left anterior descending artery. Endocardial mapping was per-
formed in all patients with VT, and cryoablation or subendocardial
scar resection was performed according to our VT protocol.9
Thereafter, under mild hypothermia (33°C-35°C), the aorta was
crossclamped and antegrade cold-blood (4°C) cardioplegic arrest
was induced.
Aneurysm resection and LV volume restoration were per-
formed using 3 methods. The type of operation was selected
depending on the extent of endocardial disease. The goal was to
restore an elliptical LV cavity and a cone-shaped apex.
In patients with minimal septal dyskinesis (group I, n  65),
radical aneurysmectomy was performed.7 This involved resection
of the entire scarred aneurysm wall, leaving a narrow rim near the
contracting endocardium laterally and medially, avoiding the left
anterior descending artery injury and entry into the right ventric-
ular cavity. A linear anterior ventriculotomy closure was per-
formed usint interrupted sutures with Teflon (DuPont, Wilming-
ton, Del) pledget reinforcement with minimal plication of the
lateral wall. Attempts were made to reconstruct the LV apex
without creating mid-ventricular narrowing.
In patients with a large dyskinetic septal scar (group II, n 
70), septal plication was performed by using interrupted sutures
reinforced with Teflon pledgets. A Teflon patch (1 mm thick) was
cut to an oval shape (with an average size of 3  5 cm) to support
the septum (septoplasty).8 The ventriculotomy was closed by in-
cluding the supported septum that was sewn to the junction of the
visible scar tissue and the myocardium (septal inclusion).
In group III (n  22), there was minimal involvement of the
septal wall. The borders of the scarred and viable (contracting)
myocardium were identified, and the ventriculotomy opening was
used to size a teardrop-shaped (or oval) patch of Dacron (Hemash-
ield; Boston Scientific Corporation, Natick, Mass) to reconstruct
the anterior wall of the LV. Moderate plication of the LV opening
was achieved by an encircling purse-string suture or spacing of the
sutures to secure the patch (Figure 1). Attempts were made to
avoid oversizing the patch (the size averaged 2  4 cm). It was
sewn in place with 1 row of continuous sutures ensuring an
ellipsoid LV cavity and a cone-shaped apex. Intraoperative trans-
esophageal echocardiography was used extensively to assess the
LV cavity size before and after the operation (Figure 2). The
medial (septal) and the lateral remnants of the scarred aneurysm
tissues were then trimmed, and the ventriculotomy was closed over
the patch (septal exclusion).
Follow-up
Patients were followed up by direct contact, telephone interviews,
and outpatient clinic visits. Follow-up intervals ranged from 15
months to 22 years (group I, 260 months; group II, 186 months;
group III, 104 months). Follow-up management was performed by
the primary care physicians. Patients were maintained on an opti-
mized regimen for treatment of congestive heart failure that in-
cluded use of  blockers and angiotensin-converting enzyme in-
hibitors. Follow-up cardiac catheterization was performed if the
patients became symptomatic. Twenty patients (14%) were lost to
follow-up because of tertiary referrals, patient migration, and un-
known reasons.
Figure 1. Surgeon’s view of the anterior wall of the heart after LV
volume restoration operation with an oval endoventricular Da-
cron patch. The black arrowheads point to the sutures that secure
the patch and the purse-string suture.
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Statistical Analysis
Data were analyzed using the SAS System (SAS Institute Inc,
Cary, NC). Continuous variables were expressed as mean  SEM
and categorical variables as frequency and percent. Univariable
analysis of categorical determinants of mortality was performed by
the 2 test and the Fisher exact test. Continuous variables were
analyzed using the analysis of variance and Student t tests. Actu-
arial survival curves (Kaplan-Meier) were used to assess differen-
tial mortality among the 3 groups. Multivariable regression anal-
ysis (Cox model) was used to assess the effect of independent
variables on survival. Wilcoxon and log-rank statistical analyses
were applied to evaluate the survival curves.
Results
The operative procedures were performed from 1979 to
2000. Initially (1979-1992), most patients underwent radical
aneurysmectomy with linear closure (group I, n  47) or
septal inclusion (group II, n  57). Septal exclusion with
endocardial patch was the technique used from 1992 to
2000 (group III, n  22), whereas other operative tech-
niques (group I, n  18; group II, n  13) were used
according to the pathologic findings as previously de-
scribed. One patient underwent septoplasty in 1977 for
acute MI, LV false aneurysm, and cardiogenic shock. He
lived 80 months.
Hospital mortality included all deaths within the same
hospitalization or within 30 days. There were 25 early
postoperative deaths (16%). The major causes of deaths
were persistent congestive failure, recurrent ventricular ar-
rhythmia, and multiorgan failure. There was no significant
difference in early deaths among the 3 groups of patients
(Table 3). For the entire group, the risk factors associated
with early mortality included class III and IV (New York
Heart Association) congestive failure (P .04), cardiogenic
shock (P  .0001), use of an intra-aortic balloon pump
(IABP) (P .0001), and emergency or urgent operations (P
 .0003).
For the entire group (including early mortality), the ac-
tuarial survival at 5, 10, and 15 years was 53%, 30%, and
Figure 2. Intraoperative transesophageal echocardiogram. The views are in systole (A, C) and diastole (B, D) before
(A, B) and after (C, D) volume reduction surgery in a patient in group III. Left atrium (LA), left ventricle (LV), mitral
valve (MV), aneurysm (A), and right ventricle (RV) are identified. The arrowheads show the extent of the anterior
endoventricular patch in systole (C) and diastole (D). Note the extent of LV volume reduction and apical restoration.
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18%, respectively (Figure 3, A). Excluding the early death,
the actuarial survival for the same intervals was 63%, 37%,
and 22%, respectively (Figure 3, B). A comparison of the
actuarial survival for the hospital survivors among the 3
groups is shown in Figure 4. At 5 years, 74% of group III
patients (with endoventricular patch) were alive in compar-
ison with 63% of group I and 58% of group II (P  .229).
Comparison of actuarial survival for all patients at risk in
group I (radical resection) and patients in group III showed
no significant difference (Figure 5, A), whereas there was a
significant difference in survival comparing all patients at
risk in group III with those in group II (septoplasty). Sur-
vival at 5 and 7 years was 47% and 37% for group II,
respectively, compared with 67% and 67% for group III,
respectively (P  .04) (Figure 5, B).
There were significant differences in the preoperative
incidence of cardiogenic shock and of urgent or emergency
operations and use of IABP among the groups. Group III
patients had the lowest number of urgent or emergency
operations 9% (2/22) compared with 40% (26/65) and 65%
(46/70) in groups I and II, respectively (P .003) (Table 3).
There was a significant difference in survival among all
patients undergoing operations electively (n  83) com-
pared with those undergoing emergency or urgent opera-
tions (n 74). Survival was 64% versus 41% at 5 years and
53% versus 34% at 7 years for elective versus urgent or
emergency operations, respectively (P  .0006, Wilcoxon;
P  .02 log-rank). However, the difference in long-term
survival among hospital survivors was not significant (P 
.31) (Figure 6, F).
The early mortality for patients with cardiogenic shock
in groups I, II, and III was 50% (4/8), 47% (8/17), and 0%
(0/1), respectively. There was significantly lower survival
(36% at 3 years) in all patients with cardiogenic shock than
in patients without cardiogenic shock (68% at 3 years, P 
.0003 by the log-rank test). However, among hospital sur-
vivors, patients with preoperative cardiogenic shock dem-
onstrated 42% survival at 5 years versus 66% in patients
without cardiogenic shock (P  .137).
The incidence of myocardial revascularization and the
number of coronary bypass grafts per patient were similar in
the 3 groups (P  .398) (Table 3). For the entire group,
among 98 hospital survivors, the survival at 5 and 10 years
was higher in patients with arterial grafts (74% and 35%)
than in patients with venous grafts only (60% and 32%),
respectively (P  .360).
Figure 3. Actuarial survival for all patients at risk including (A) and excluding (B) early (operative) mortality.
Figure 4. Comparison of actuarial survival in the 3 patient groups
after LV volume reduction surgery: group I, radical resection;
group II, septoplasty; group III, endoventricular patch. P  .2290.
Surgery for Acquired Cardiovascular Disease Bolooki et al
378 The Journal of Thoracic and Cardiovascular Surgery ● August 2003
A
CD
Multivariate analysis was performed to identify the risk
factor(s) that affected the late mortality. A total of 24 factors
were considered including the following: operative tech-
nique, age, ejection fraction (EF), PAO pressure, cardiac
index, VT, cryoablation, congestive heart failure, cardio-
genic shock, recent MI, use of arterial grafts, urgency of
operation, and need for IABP. Preoperative factors that
significantly affected the survival of all patients at risk and
Figure 5. Actuarial survival including the early mortality comparing the results for the 3 operative techniques. A,
All patients at risk in groups I and III are compared. P  .1591. B, All patients at risk in groups II and III are
compared.
Figure 6. Actuarial late survival excluding early death according to preoperative variables: ejection fraction (EF),
pulmonary artery occlusive (PAO) pressure, intra-aortic balloon pump (IABP), and ventricular tachyarrhythmia (VT).
D, P  .3356; E, P  .2427; F, P  3184.
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hospital survivors included EF (26%), PAO pressure
(17 mm Hg), and no IABP (Table 4 and Figure 6, A-C).
Factors that influenced early death but had no significant
effect on long-term survival included preoperative conges-
tive failure, VT, cardiogenic shock, recent MI, and emer-
gency versus elective operations (Figure 6, D-F).
There were 76 deaths during the follow-up period (Table
5). Congestive heart failure was the most frequent cause.
Cause of death was unknown in 11 instances. The hearts
from 8 patients (in groups I and II) who died 6 months to 3
years postoperatively were examined by pathologists. The
position and the extent of healing of the septal patch were
impressive (Figure 7).
One patient in group III underwent cardiac transplanta-
tion and is doing well. On their last visit, the 36 surviving
patients were in New York Heart Association symptom
class I or II. Fourteen of these patients were older than 72
years and lived independently. Late cardiac catheterization
data (5-16 years postoperatively) from 7 patients were re-
viewed. The LV angiogram in 5 patients showed decreased
LV end-systolic and end-diastolic volumes and a slightly
improved EF (Figure 8).
Discussion
LV remodeling is a natural consequence of transmural
MI.10,11 It is enhanced by the extent of infarction and is a
sequela of infarct expansion and wall stretch. These ana-
tomic changes initially ameliorate cardiac dynamics in the
form of an increase in blood pressure and cardiac output and
a decrease in end-diastolic pressure, although at the expense
of increase in LV volume, wall stress, and wall tension (La
Place law).
Surgical methods of eliminating the noncontractile areas
of the LV have been used since 1958.12 The procedure is
universally accepted. It improves cardiac systolic perfor-
mance and in conjunction with myocardial revascularization
improves long-term survival results.13-15 In recent years, a
combination of medical management using percutaneous
methods of revascularization followed by afterload reduc-
tion and -blocker therapy has played a highly successful
role in the prevention of LV aneurysm formation and re-
modeling.16
The intracavitary repair of LV aneurysm is a technique
that has evolved as the result of the observation of a thin-
walled cardiac septum that could not be resected and was
frequently associated with a patent anterior descending ar-
tery suitable for bypass grafting.17-20 Few reports have been
published that compare the late survival results (5 years)
with various methods of LV volume reduction.18,21 The
early results have shown similar survival among the patient
groups. No randomized trials have been performed.
A survey of changes in cardiac function and volume after
the 3 types of repair, as discussed here, has been reported
and is beyond the intent of this work.1,2,7,8,21 The incidence
of preoperative congestive heart failure, angina, and recent
MI in our study was similar in the 3 groups of patients and
matches the reports by other investigators.5,13,14 The larger
number of patients with VT in our study was possibly the
result of referrals to our Sudden Death Center during the
1980s when catheter ablative therapy was not available. In
recent years, the incidence of ventricular aneurysm surgery
in general and the referral rate for surgical treatment of VT
in particular have substantially declined.1,15
In this study, a comparison of preoperative hemody-
namic factors shows a difference in EF, cardiac index, and
end-diastolic pressure in the 3 patient groups. The differ-
ence was significant in group III who had lower EF (22%)
and higher pulmonary occlusive pressure (20 mm Hg) and
end-diastolic pressure (23 mm Hg) values compared with
groups I and II (Table 3). This difference may have nega-
tively influenced the operative mortality (13%) and long-
term survival of patients in group III. Despite a more
depressed cardiac function, group III patients had a higher
survival at 5 and 7 years compared with group II patients
(67% vs 47% P  .04) (Figure 4). However, other factors,
such as newer therapeutic regimen (eg, angiotensin-convert-
ing enzyme inhibitors and  blockers), may have contrib-
uted to the improved survival in group III as well.
A significant decrease in pulmonary occlusive (wedge)
pressure after aneurysm resection has been reported by a
number of investigators.15,17,21 Similarly, an elevated LV
end-diastolic pressure markedly decreases postoperative-
ly.4,13,14 For these reasons, we considered an elevated pre-
operative PAO pressure as a possible factor that may prog-
nosticate long-term survival after the operation. The
TABLE 4. Cox regression analysis of multivariable predic-
tors of late mortality in all hospital survivors after left
ventricular volume reduction surgery
Variable Hazard ratio 95 % CI 2 P value
IABP 2.27 1.47–3.5 13.8 .0002
EF 1.49 1.01–2.20 3.9 .045
PAO 1.54 1.08–2.21 4.0 .044
CI, Confidence interval.
TABLE 5. Causes of late death
Cause
All patients
(n  76)
Group I
(n  37)
Group II
(n  38)
Group III
(n  1)
CHF 31 11 19 1
SD 14 5 9 —
MI 12 6 6 —
Cancer/sepsis 8 4 4 —
Unknown/other 11 11 — —
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accepted maximum normal value of 18 mm Hg was con-
sidered to be the cutoff point. There was a significant
difference in survival (P  .05) among hospital survivors
with preoperative PAO pressure of 17 mm Hg or less and
those with PAO pressure of 18 mm Hg or greater. This
finding is not supported by previous reports, probably be-
cause of the lack of survival analysis considering this factor
or use of mean pulmonary artery pressure readings.5,21,22
Mickleborough and colleagues15 have considered severe
pulmonary hypertension as a contraindication to this proce-
dure. We believe that patients with a high intracardiac
diastolic pressure and congestive failure in association with
preserved LV systolic function have diastolic dysfunction.23
This condition may not improve with LV volume reduction
surgery, especially in patients with a mostly akinetic LV
aneurysm. Instead, these patients may benefit from circula-
tory assist devices aiming for cardiac transplantation.
The incidence of cardiogenic shock and the use of an
IABP were higher in this study compared with other re-
ports.14,15,21 As shown in Table 4, the use of an IABP was
associated with a high probability of poor early and late
outcomes. Factors that showed no significant effect on long-
term survival, if the initial operative mortality was ex-
cluded, were congestive heart failure, preoperative VT, the
use of arterial grafts for coronary bypass, and whether the
operation was urgent, emergency, or elective (Figure 6). In
this regard, the results of our study do not conform to some
of the previous reports that involved follow-up times of 2 to
5 years.3,15,24 A longer follow-up may be necessary to
clarify these points.
In the past, the goals of surgical management of patients
with a large anteroseptal LV aneurysm involved the elimi-
nation of the dyskinetic segment with little regard to the
restoration of LV cavity size and shape. In recent years, the
functional significance and the effects on long-term survival
of LV configuration have been realized.19,24-26 Our study
shows that if these concerns are met, the survival results of
surgical management of LV aneurysm will be satisfactory,
especially with the endoventricular patch technique.
Recently, Athanasuleas and colleagues4 reported for the
RESTORE group of surgeons on 439 patients who were
studied prospectively and had received anterior ventricular
patch repair. There was an in-hospital mortality rate of
6.6%, a balloon pump was used in 7% of patients, and the
preoperative EF was 29%  10% (SD). The overall early
survival (at 18 months) was 84%. These early results are
impressive and probably the result of proper patient selec-
tion and the experience of the entire group. In an elegant
Figure 7. Heart specimen showing mid-ventricular section 6 months after volume reduction surgery with septo-
plasty technique (group II). The septal patch (white arrowheads), right ventricle (RV), left ventricle (LV), septum (S),
and patent anterior descending artery (A) are shown. This patient died suddenly of cardiac dysrhythmia probably
caused by a posterior septal infarction (black arrowheads). White arrows indicate 2 implanted defibrillator
patches. Note the suture line (black arrow), the thick wall LV cavity, and the septal wall with the Teflon patch.
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monograph, Buckberg and colleagues27 described in detail
the basis for their concept in repairing the LV cavity con-
sidering the oblique anterior ventricular wall fiber orienta-
tion. The reconstruction of the anterior wall and the apex
cone was accomplished with a 2  3-cm patch.28 We used
a larger patch with an average size of 2  4 cm (in group
III) that was cut to an ovoid shape to accommodate the LV
outflow and construct the LV apex. It is possible that
downsizing the patch would play a role in patient survival
by decreasing the LV volume. The LV end-systolic volume
index has been shown to significantly affect patient survival
and freedom from cardiac morbidity.5
With recent improvement in medical and surgical treat-
ment of ischemic heart disease, the indications for volume
restoration surgery have expanded to include patients with
small aneurysms and minimal symptoms.29 The variability
of indications for this operation necessitates a prospective
randomized trial to identify the method of treatment that
consistently improves the long-term survival of these pa-
tients.
Drs Gerald Kaiser, Richard Perryman, Michael Horowitz, Ken-
neth Herskowitz, and George Palatianos (presently director of
Cardiac Surgery Service at Onassis Cardiac Center in Athens,
Greece) collaborated in the early part of this study. I am grateful
to Mrs Joanne Bolooki for typing and editing this manuscript.
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Discussion
Dr Gerald D. Buckberg (Los Angeles, Calif). I would like to
compliment Dr Bolooki for an important review of the geometric
changes after anterior infarction that link the evolution of correc-
tive measures with early and late results. Improvement followed
changing from a linear resection to include the septum, to plicating
the dyskinetic septum with a triangular patch as described in 1986,
to more recently excluding the septum with an oval patch to restore
an elliptical shape. The composite results may lead to some con-
fusion because different reasons can explain why high-risk com-
ponents of EF, pulmonary artery pressure, and the need for a
balloon will raise mortality. From a mechanical standpoint, patch
exclusion of the septum is a more complete procedure and was
more successful in his presentation, despite the occurrence of the
lowest EF of 22% and highest PA pressure of 21 mm Hg. Fur-
thermore, adding patients with cardiogenic shock raises early
mortality. Is their analysis without this data available?
Dr Bolooki. Yes. The article has more detailed data analysis.
You are correct, patients with an intraventricular patch had overall
higher survival results.
The composite slide (Figure 6) showed that by excluding the
operative mortality, there is approximately a 10% better survivor-
ship at 5 years, 7% at 10 years, and 4% at 15 years for the 3 patient
groups. There were no statistically significant differences in over-
all survival among the 3 groups at 5 years. However, at 7 years of
follow-up, the difference in survival was better for group III (patch
exclusion of the septum) than for group II (septal inclusion).
Preoperative use of a balloon pump, cardiogenic shock, and emer-
gency operations had a significant effect on operative (in-hospital
death) survival, but only balloon-pump use had an effect on
long-term survival curves.
Dr Buckberg. I think that is correct, because a clearer picture
emerges when you look at elective high-risk patients. We recently
analyzed 662 patients, mostly in class III or IV heart failure, and
the balloon was only needed in approximately 8%. Hospital mor-
tality for restoration without repair was approximately 4%, so that
goes along with what you are saying. I think that separating
elective versus urgent operations will reduce the mortality as you
describe, and you demonstrate that in your slide.
It seems that the consideration of methods of protection may
suggest that the beating empty heart, rather than cardioplegia, may
be useful for restoration when there is trabecular scar. This is
because aneurysms are fairly rare today with the use of thrombol-
ysis and percutaneous transluminal coronary angioplasty. How-
ever, the akinetic heart is relatively common. The thick akinetic
heart is seen by echocardiography and ventriculography, and it
does not collapse by venting. The junction between contracting
and noncontracting muscle is found by palpation. I wonder how
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